NCT06062563 2023-10-02
Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase NA Unknown
Clinical Trials
1 trialsLocally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma × Head & Neck × Clear all